DPH Stock Overview
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.
Dechra Pharmaceuticals PLC Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£35.68|
|52 Week High||UK£55.25|
|52 Week Low||UK£30.66|
|1 Month Change||-2.25%|
|3 Month Change||8.65%|
|1 Year Change||-30.31%|
|3 Year Change||23.29%|
|5 Year Change||92.97%|
|Change since IPO||2,603.03%|
Recent News & Updates
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|DPH||GB Pharmaceuticals||GB Market|
Return vs Industry: DPH underperformed the UK Pharmaceuticals industry which returned 5.2% over the past year.
Return vs Market: DPH underperformed the UK Market which returned -9% over the past year.
|DPH Average Weekly Movement||5.2%|
|Pharmaceuticals Industry Average Movement||6.4%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: DPH is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: DPH's weekly volatility (5%) has been stable over the past year.
About the Company
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies.
Dechra Pharmaceuticals PLC Fundamentals Summary
|DPH fundamental statistics|
Is DPH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DPH income statement (TTM)|
|Cost of Revenue||UK£276.70m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Sep 05, 2022
|Earnings per share (EPS)||0.64|
|Net Profit Margin||11.38%|
How did DPH perform over the long term?See historical performance and comparison